Funded Tech Companies
Inozyme Pharma
Wondering who provided funding to Inozyme Pharma? Sanofi-Genzyme BioVentures, Novo Ventures and Cowen Capital Partners joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Inozyme Pharma
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
280 Summer St. 5th Floor
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Company Background Information
Overview
Inozyme Pharma (Nasdaq: INZY) is a biotechnology company developing new medicines to treat rare disorders of calcification. These diseases are characterized by mineral imbalances, which lead to over calcification of soft tissues and under mineralization of bone.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/24/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Axel Bolte
Chief Operating Officer
Henric Bjarke
Chief Scientific Officer
David Thompson
Chief Technical Officer
Steven Jungles
VP - Finance
Stephen Basso
Company Investors
- Sanofi-Genzyme BioVentures
- Novo Ventures
- Cowen Capital Partners
- Pivotal bioVenture Partners (Robert Hopfner)
- New Enterprise Associates
- Longitude Capital Management
- Rock Springs Capital
- Sofinnova Ventures (Sarah Bhagat)
- RA Capital
- Novo Ventures (Martin Edwards)
- New Enterprise Associates (Ed Mathers)
- Longitude Capital Management (Reinaldo Diaz)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs